Wellcome Leap Inc. – Interim award (360G-Wellcome-220960_Z_20_Z)
In early February 2020 Wellcome’s BoG approved the appointment of Regina Dugan as CEO of the Wellcome Leap Fund (WLF), the relocation of the WLF’s primary place of business to the U.S. and the creation of a U.S. not-for-profit entity within the Wellcome group (Leap US). This grant is a mobilisation fund to support the initial activities required for Leap US’ set up and strategy development, prior to the awarding of full grant which will be administered upon BoG approving the CEO’s strategy and business plan for the WLF.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Region | International |
| Award Date | 2020-09-30T00:00:00+00:00 |
| Internal ID | 220960/Z/20/Z |
| Planned Dates: End Date | 2021-03-29T00:00:00+00:00 |
| Planned Dates: Start Date | 2020-03-30T00:00:00+00:00 |
| Amount Awarded | 782901.43 |
| Financial Year | 2019/20 |
| Lead Applicant | Dr Regina E Dugan |
| Grant Programme: Title | Wellcome Leap Inc. |
| Applicant Surname | Dugan |
| Approval Committee | Internal Decision Panel |
| Recipient Org: Country | United States |
| Recipient Org: City | Wilmington |
| Has the grant transferred? | No |
| Research conducted at multiple locations? | No |
| Total amount including partnership funding | 782901.43 |